Where we invest
M13 started investing in 2016 in DTC and B2B models. Starting with Fund II, we evolved our focus from consumer to a broader infrastructure strategy. Today, we invest in infrastructure technology—such as AI and web3—that powers the future of work, health, commerce, and money.
Read our investment thesis to learn more.
Investing in infrastructure
We invest in the powerful infrastructure technologies such as web3 and AI that power our vertical focus areas.
.png)
.png){kind=logo}
.png){kind=logo}
.avif)
.png)
.png)
.png){kind=logo}
.png){kind=logo}
.png)
.png)
.png)
.png)
.png)
.png){kind=logo}
.png)
.png)
.png)
.png)
.webp)
.png)
.png)
.png)
.png)
.png){kind=logo}
.png)
.png)
.png){kind=logo}
.png)
.png)
.avif)
.png)
.png)
.png)
Turning experience into insights
Meet Morgan: why the future of AI is boring, regulated and wildly profitable
Morgan Blumberg is a partner at M13 known for a contrarian thesis on agentic workflow automation. She invests in AI that replaces painful back office work in healthcare and enterprise. Her portfolio spans NormAI, Maven AGI, Niural, Kontext, PIKL, RadiantGraph, Polimorphic, Canvas Medical, Ayble Health, Lantern, Play, Workmade and Vambe.
.webp)
.webp)
.png)